Martha Arellano - Concepedia

Author

Martha Arellano

Also Known As

Arellano, Martha, M Arellano, M L Arellano, M. Arellano, M. L. Arellano, M. arellano, M.L. Arellano, MARIA I.ROBERT de RAMIREZ de ARELLANO, Martha Arellano, Martha L Arellano

268

Publications

12.9K

Citations

H-Index

Concepts

All Affiliations

Emory University The University of Texas MD Anderson Cancer Center University of Chicago Memorial Sloan Kettering Cancer Center Dana-Farber Cancer Institute

About

Martha Arellano is an author at Emory University specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	35	4K
2	Health Sciences	8	8	1.8K
3	Biochemistry	7	7	1.4K
4	Natural Sciences	5	5	543
5	Biomolecular Engineering	1	1	24

Martha Arellano

100

Publications

12K

Citations

H-Index

Page 1

	Year	Citations
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia Courtney D. DiNardo, Keith W. Pratz, Vinod Pullarkat, Blood	2018	1.8K
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton, New England Journal of Medicine	2018	1.4K
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole, The Lancet Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematology	2021	721
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study Courtney D. DiNardo, Keith W. Pratz, Anthony Letai, The Lancet Oncology Hematological MalignancyOncologyElderly PatientsMixed-phenotype Acute LeukemiaHematology	2018	692
Salivary Proteomics for Oral Cancer Biomarker Discovery Shen Hu, Martha Arellano, Pinmanee Boontheung, Clinical Cancer Research	2008	542
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio, Nature	2023	420
Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth Taro Hitosugi, Lu Zhou, Shannon Elf, Cancer Cell BiochemistryMedicineTumor GrowthPhosphoglycerate Mutase 1Protein Phosphorylation	2012	418
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia Gail J. Roboz, Courtney D. DiNardo, Eytan M. Stein, Blood	2019	363
Glutamate Dehydrogenase 1 Signals through Antioxidant Glutathione Peroxidase 1 to Regulate Redox Homeostasis and Tumor Growth Lingtao Jin, Dan Li, Gina N. Alesi, Cancer Cell Reductive StressRedox SignalingBiochemistryRedox RegulatorTumor Growth	2015	353
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster, Blood	2020	307

Page 1